Search

Your search keyword '"Nakamura, Masato"' showing total 3,406 results

Search Constraints

Start Over You searched for: Author "Nakamura, Masato" Remove constraint Author: "Nakamura, Masato"
3,406 results on '"Nakamura, Masato"'

Search Results

1. Ramucirumab for advanced hepatocellular carcinoma in the current real world: a Japanese single-arm study post-REACH-2 (The R-evolution study)

3. CVIT expert consensus document on primary percutaneous coronary intervention (PCI) for acute coronary syndromes (ACS) in 2024

4. Twenty-Four-Month Safety and Effectiveness of TCD-17187 Drug-Coated Balloon for Treatment of Atherosclerotic Lesions in Superficial Femoral and Proximal Popliteal Artery

5. Clinical risk factors for portal hypertension-related complications in systemic therapy for hepatocellular carcinoma

6. Coronary events in elderly patients with non-valvular atrial fibrillation: a prespecified sub-analysis of the ANAFIE registry

7. Exploratory Biomarker Analysis Using Plasma Angiogenesis-Related Factors and Cell-Free DNA in the TRUSTY Study: A Randomized, Phase II/III Study of Trifluridine/Tipiracil Plus Bevacizumab as Second-Line Treatment for Metastatic Colorectal Cancer

9. Reflectivity of Venus' dayside disk during the 2020 observation campaign: outcomes and future perspectives

10. Cabozantinib for Advanced Hepatocellular Carcinoma in the Latest Real-World Practice: A Multicenter Retrospective Analysis

11. Multicenter phase II study of capecitabine plus oxaliplatin in older patients with advanced gastric cancer: the Tokyo Cooperative Oncology Group (TCOG) GI-1601 study

13. External validation of the Pulmonary Embolism-Syncope, Anemia, and Renal Dysfunction bleeding score for early major bleeding in patients with acute pulmonary embolism: from the COMMAND VTE Registry-2

15. Geographic disparity of pathophysiological coronary artery disease characteristics: Insights from ASET trials

16. Potential of circulating receptor-interacting protein kinase 3 levels as a marker of acute liver injury

17. Estimation of the effect of atezolizumab plus bevacizumab on pulmonary arterial hypertension using computed tomography in HCC patients

18. Use of ramucirumab for various treatment lines in real-world practice of patients with advanced hepatocellular carcinoma

19. Hyperprogressive disease during atezolizumab plus bevacizumab treatment in patients with advanced hepatocellular carcinoma from Japanese real-world practice

20. Trifluridine/tipiracil+bevacizumab (BEV) vs. fluoropyrimidine-irinotecan+BEV as second-line therapy for metastatic colorectal cancer: a randomised noninferiority trial

21. A Multicenter, Phase II Trial of Schedule Modification for Nab-Paclitaxel in Combination with Ramucirumab for Patients with Previously Treated Advanced Gastric or Gastroesophageal Junction Cancer: The B-RAX Trial (JACCRO GC-09)

24. A diet-induced murine model for non-alcoholic fatty liver disease with obesity and insulin resistance that rapidly develops steatohepatitis and fibrosis

25. Clinical expert consensus document on standards for lower extremity artery disease of imaging modality from the Japan Endovascular Treatment Conference

26. Planetary-scale variations in winds and UV brightness at the Venusian cloud top: Periodicity and temporal evolution

28. Alteration of the tumor microenvironment by pharmacological inhibition of EZH2 in hepatocellular carcinoma

29. Nightside Winds at the Lower Clouds of Venus with Akatsuki/IR2: Longitudinal, local time and decadal variations from comparison with previous measurements

31. Liver biopsy technique in the era of genomic cancer therapies: a single-center retrospective analysis

33. Efficacy and safety of regorafenib dose-escalation therapy for Japanese patients with refractory metastatic colorectal cancer (RECC study)

35. SAT-176 Itg-Cre/DTA mice develop the autoimmune biliary disease that serologically and pathogenically models human primary biliary cholangitis

36. SAT-335 Pathological dynamics and clinical implications of hepatitis in cancer patients undergoing immune checkpoint inhibitor

37. Assessment of Macrovascular Invasion in Advanced Hepatocellular Carcinoma: Clinical Implications and Treatment Outcomes with Systemic Therapy

38. Impact of High-Voltage Device Implantation in Elderly Japanese Patients With Heart Failure as Primary Prevention ― Post Hoc Analysis of HINODE ―

39. Antithrombotic therapy for stable coronary artery disease and atrial fibrillation in patients with and without revascularisation: the AFIRE trial

40. Relationship between platelet aggregation and stroke risk after percutaneous coronary intervention: a PENDULUM analysis

42. Independent Predictors of Major Adverse Cardiovascular Events at 3 Years after Aortoiliac Stent Implantation

44. Catheter-based ultrasound renal denervation in patients with resistant hypertension: the randomized, controlled REQUIRE trial

45. CVIT expert consensus document on primary percutaneous coronary intervention (PCI) for acute myocardial infarction (AMI) update 2022

47. Impact of early tumor shrinkage on quality of life in patients treated with first-line cetuximab plus chemotherapy for unresectable metastatic colorectal cancer: results of Phase II QUACK trial

48. The efficacy of contrast-enhanced computed tomography on the management of gastroesophageal varices in patients with hepatocellular carcinoma

Catalog

Books, media, physical & digital resources